Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Perrigo

This article was originally published in The Tan Sheet

Executive Summary

Deferral from OTC labeling final reg for Suphedrine Cold & Cough Liquid-Filled Capsules and Day Time Liquid-Filled Capsules sought pending FDA response to private labeler's October 2000 exemption request to allow use of phrase "may contain" when listing inactives. "Due to the time needed to change labeling specifications, develop customer-specific art, obtain customer approval, print labeling components and label finished product, it is necessary that Perrigo initiate a labeling conversion now" to convert products by May 16, 2002 compliance date, firm says Aug. 9
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS092987

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel